Agarwal, N., Vaishampayan, U. N., Zhang, J., Artignan, X., Mellado, B., Wong, S. S., Parikh, O., Castellano, D., Baranda, J. C., Williamson, D., Gunachandran, L., Guo, X., Nandoskar, P., McGregor, B. A., Pal, S. K. (2025). Cabozantinib (C) ± atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Expansion cohorts from the open-label phase 1b COSMIC-021 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.145